Pharmaceutical

ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million in Partnership with Williamsburg Venture Holdings to Fund Clinical Development of Cholesterol Efflux Mediator™ VAR 200

WESTON, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company...

Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results

Salanersen (BIIB115/ION306) is a novel antisense oligonucleotide (ASO) with the potential to achieve high efficacy and once yearly dosing in...

Cognition Therapeutics Provides Regulatory Update on Zervimesine (CT1812) in Alzheimer’s Disease and Dementia with Lewy Bodies (DLB)

- End-of-Phase 2 Meeting with FDA for Mild-to-Moderate Alzheimer’s Disease Scheduled - - Applications for IND and Breakthrough Status Filed...

Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer

Phase 1/2a clinical trial currently supported by a $3.0 million grant from the U.S. Department of Defense Trial will enroll...

Oncotelic Therapeutics Announces Publication of Landmark Study on TGFB2 Gene Methylation as a Positive Prognostic Marker in Pancreatic Cancer

AGOURA HILLS, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) ("Oncotelic" or the "Company"), a clinical-stage...

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit

WARREN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company...

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort

-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in fourth cohort, permitting dose escalation in expected final cohortMarlborough,...

Kicking Off Today! Process Intensified. Drug Manufacturing Accelerated. The Sartorius PI Forum opens in Boston — shaping biomanufacturing’s future

Sartorius launches a premier industry event focused on process intensification (PI) for protein therapeutics and emerging modalities.Forum features expert-led sessions,...

Label-free Detection Market to Accelerate Growth from USD 2.64 Billion to USD 4.48 Billion by 2032 – Meticulous Research®

Rising Pharmaceutical Innovation, AI Integration, and Point-of-Care Testing Applications Drive 9.8% CAGR Growth Across Healthcare and Biotechnology Sectors Worldwide REDDING,...

Calibre One Welcomes Jed Donnelly as Partner, Strengthening Life Sciences and Biopharma Expertise in The Firm’s Rapidly Expanding Healthcare Practice

BOSTON, June 24, 2025 /PRNewswire/ -- Calibre One, a leading global executive search firm specializing in building world-class leadership teams,...

MedWellAi, Inc (formerly Integrated Ventures) Completes Corporate Rebranding And Transformation Into Ai-Driven Healthcare and Wellness

CLEARWATER, Fla., June 24, 2025 /PRNewswire/ -- MedWell Ai, Inc, (New Symbol/OTCQB: MWAI) is pleased to provide this Corporate Update,...

Global Genes and Boston Children’s Hospital Partner for 2025 RARE Drug Development Symposium – Equipping Rare Disease Advocates in Research and Drug Development

This Event Will Build Knowledge, Strategy, and Confidence for Patient Advocacy Leaders to Drive Therapeutic Innovation in Partnership with Life...

error: Content is protected !!